Facebook Pixel Code

Everest Organics Share Price

NSE
BSE

EVEREST ORGANICS

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Everest Organics along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹480.00 Closed
-0.54₹ -2.60
As on Dec 17, 2025, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Everest Organics Price Performance

Today's LowToday's High
₹452.05₹480.00
₹480.00
52 Weeks' Low52 Weeks' High
₹210.95₹499.00
₹480.00
Open Price
₹480.00
Prev. Close
₹482.60
Volume
810

Over the last 5 years, the share price of Everest Organics has gained 12.99% CAGR. Over the past year, the corresponding return has been 105.48%.

Everest Organics’s current P/E of 70.47x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.

Everest Organics Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Everest Organics
1.697.2016.3631.51105.4856.4112.99
Sun Pharmaceutical Industries
0.321.6010.608.680.1421.9625.69
Divi's Laboratories
-0.03-3.563.97-3.767.5623.4110.46
Torrent Pharmaceuticals
-0.96-1.586.0115.5111.1433.0122.19
Cipla
0.56-2.53-3.96-0.403.2410.9513.84
Dr. Reddy's Laboratories
1.592.13-3.05-3.641.8413.054.60
Lupin
2.662.833.878.553.1242.5316.80
Zydus Lifesciences
-0.63-1.76-11.31-4.28-5.3330.8914.08
Mankind Pharma
-1.74-6.00-17.85-10.30-20.7014.018.18
Aurobindo Pharma
1.51-3.898.477.17-2.0139.536.40
Alkem Laboratories
0.29-1.902.5416.654.1923.2213.84
Abbott India
-1.25-6.50-10.56-12.97-1.189.8611.43
Glenmark Pharmaceuticals
-0.484.17-4.8317.5228.4867.1330.30
Laurus Labs
-0.88-1.2812.9552.7876.6437.5524.16
Biocon
2.02-8.249.099.6610.1913.70-3.45
GlaxoSmithKline Pharmaceuticals
-0.443.57-5.68-20.6713.9224.6810.23
Anthem Biosciences
3.03-0.26-23.13-9.12-9.12-3.14-1.89
Ipca Laboratories
-5.00-4.916.042.52-10.7017.645.16
Ajanta Pharma
-1.894.061.692.29-9.3230.3118.76
J B Chemicals & Pharmaceuticals
-1.77-2.365.023.09-2.6620.0026.95

Over the last one year, Everest Organics has gained 105.48% compared to peers like Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (7.56%), Torrent Pharmaceuticals (11.14%). From a 5 year perspective, Everest Organics has underperformed peers relative to Sun Pharmaceutical Industries (25.69%) and Divi's Laboratories (10.46%).

Everest Organics Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Everest Organics Stock Technicals

Moving Average

DaySMAEMA
5474.11473.33
10450.42461.88
20440446.87
50415.85425.01
100396403.41
200366.8363.13

Everest Organics Share Holding Pattern

In the latest quarter, Everest Organics saw a drop in promoter holding to 59.64%, while DII stake unchanged at 0.02%, FII holding unchanged at 0.00%, and public shareholding moved up to 40.35% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Everest Organics Corporate Actions

Date Time
Announcement
Dec 17, 2025, 4:44 PM ISTEverest Organics - Intimation Of Newspaper Publication With Respect To Special Window For Re-Lodgement Of Physical Share Tran
Dec 12, 2025, 4:05 PM ISTEverest Organics - Monthly Report On Special Window For Re-Lodgement Of Transfer Request Of Physical Shares For The Month Of
Nov 15, 2025, 8:38 PM ISTEverest Organics - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Nov 13, 2025, 2:41 AM ISTEverest Organics - Announcement under Regulation 30 (LODR)-Change in Directorate
Nov 13, 2025, 1:22 AM ISTEverest Organics - Announcement Under Regulation 30- Outcome Of Board Meeting Dated November 12, 2025

About Everest Organics

Everest Organics Ltd. is a Public Limited Listed company incorporated on 19/02/1993 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1993PLC015426 and registration number is 015426. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 159.48 Cr. and Equity Capital is Rs. 9.71 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Prasad Venkata Satya Sundara Srikakolapu
    Chairman & Ind.Director
  • Dr. Sri Kakarlapudi Sirisha
    Managing Director
  • Mr. Srikakarlapudi Harikrishna
    Whole Time Director
  • Mr. Kirankumar Rampally
    Non Exe.Non Ind.Director
  • Mr. Venkata Satyanarayana Murthy Vadali
    Independent Director

FAQs on Everest Organics Share Price

What is the share price of Everest Organics?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Everest Organics is ₹480.00 as on Dec 17, 2025.

What kind of stock is Everest Organics?

The Everest Organics is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Everest Organics?

The market cap of Everest Organics is ₹466.11 Cr as on Dec 17, 2025.

What are today's High and Low prices of Everest Organics?

Today’s highest and lowest price of Everest Organics are ₹480.00 and ₹452.05.

What are the 52 Week High and 52 Week Low of Everest Organics?

The 52-week high/low is the highest and lowest price at which Everest Organics stock has traded in the past 52-week or nearly a year. The 52-week high of Everest Organics is ₹499.00 and 52-week low of Everest Organics is ₹210.95 as on Dec 17, 2025.

How has the Everest Organics performed historically in terms of returns?

The Everest Organics has shown returns of -0.54% over the past day, 7.2% for the past month, 16.36% over 3 months, 105.48% over 1 year, 56.41% across 3 years, and 12.99% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Everest Organics?

P/E ratio of and PB ratio of Everest Organics are 70.47 and 11.04 on Dec 17, 2025. While the company gives a dividend yield of 0.00 per annum.

Everest Organics News

icon
Market Pulse